|
|
|
| History, problem and prospect of cervical cancer FIGO staging system |
| WANG Tong WU Yumei |
| Department of Gynecologic Oncology, Beijing Obstetrics & Gynecology Hospital, Capital Medical University, Beijing 100006, China |
|
|
|
Abstract Cervical cancer staging-system is the first designed staging system for gynecological cancer and the only system has not been changed to surgical-pathological system. Through reviewing the designed history of cervical cancer can understand the persistent problems of the clinical staging system. Recently exploration of surgical-pathological system for cervical cancer is hot point. More accuracy imaging examination methods such as PET-CT, MRI, CT are used to detect metastatic lymph nodes in patients with cervical cancer, specially surgical pelvic and paraaortic lymphadenectomy or lymph nodes biopsy (including laparotomy, abdominal and Robotic-Assisted) being applied in cervical cancer surgical-pathologic staging and scoring system explore a new and accuracy assessment way.
|
|
|
|
|
|
[1] Ferlay J，Shin HR，Bray F，et al. Estimates of worldwide burden of cancer in 2008：GLOBOCAN 2008 [J]. Int J Cancer J Int Du Cancer，2010，127（12）：2893-2917.
[2] 赫捷，赵平，陈万青.2012中国肿瘤登记年报[M].北京：军事医学科学出版社，2012：33-38.
[3] Odicino F，Pecorelli S，Zigliani L，et al. History of the FIGO cancer staging system [J]. Int J Gynaecol Obstetr，2008， 101（2）：205-210.
[4] Hoffman MS，Cardosi RJ，Roberts WS，et al. Accuracy of pelvic examination in the assessment of patients with operable cervical cancer [J]. Am J Obstet Gynecol，2004， 190（4）：986-993.
[5] Baltzer J，Kopcke W，Lohe KJ，et al. Surgical treatment of cervix cancer：treatment results and data on the postoperative course over a minimum of 5 years following uniform surgery and standardized histological examination of the histological material of 1092 patients at 4 university gynecology clinics [J]. Geburtshilfe Frauenheilkd，1984，44（5）：279-285.
[6] Onnis A，Marchetti M，Maggino T，et al. Management of cervical cancer and surgical-pathological staging（SPS）. Report of our clinical case series [J]. Eur J Gynaecol Oncol，1988，9（2）：115-119.
[7] Macdonald OK，Chen J，Dodson M，et al. Prognostic significance of histology and positive lymph node involvement following radical hysterectomy in carcinoma of the cervix [J]. Am J Clin Oncol，2009，32（4）：411-416.
[8] Chen Z，Huang K，Lu Z，et al. Risk model in stage IB1-IIB cervical cancer with positive node after radical hysterectomy [J]. Onco Targets Ther，2016，27（9）：3171-3179.
[9] Rotman M，Sedlis A，Muderspach LI，et al. A phase Ⅲrandomized trial of postoperative pelvic irradiation in stage IB cervical carcinoma with poor prognostic features：follow-up of a gynecologic oncology group study [J]. Int J Radiat Oncol Biol Phys，2006，65（1）：169-176.
[10] Colturato LF，Signorini Filho RC，Fernandes RC，et al. Lymph node micrometastases in initial stage cervical cancer and tumoral recurrence [J]. Int J Gynaecol Obstet，2016，133（1）：69-75.
[11] Fields EC，Weiss E. A practical review of magnetic resonance imaging for the evaluation and management of cervical cancer [J]. Radiation Oncol，2016，11（1）：1-10.
[12] Sironi S，Villa G，Rossi S，et al. Magnetic resonance imaging in the evaluation of parametrial invasion of carcinoma of the cervix uteri：optimization of the study protocol [J]. La Radiologia Medica，2001，101（6）：477-484.
[13] Sironi S，Bellomi M，Villa G，et al. Clinical stage Ⅰ carcinoma of the uterine cervix value of preoperative magnetic resonance imaging in assessing parametrial invasion [J]. Tumori，2002，88（4）：291–295.
[14] Mitchell DG，Snyder B，Coakley F，et al. Early invasive cervical cancer：tumor delineation by magnetic resonance imaging，computed tomography，and clinical examination，verified by pathologic results，in the ACRIN 6651/GOG 183 Intergroup Study [J]. J Clin Oncol，2006，36 （24）：5687-5694.
[15] Belhocine T，Thille A，Fridman V，et al. Contribution of whole-body 18FDG PET imaging in the management of cervical cancer [J]. J Gynecol Oncol，2002，87（10）：90-97.
[16] Gouy S，Morice P，Narducci F，et al. Nodal-staging surgery for locally advanced cervical cancer in the era of PET [J]. Lancet Oncol，2012，13（5）：e212.
[17] Reinhardt MJ，Ehritt-Braun C，Vogelgesang D，et al. Metastatic lymph nodes in patients with cervical cancer：detection with MR imaging and FDG PET [J]. Radiology，2001，218（3）：776-782.
[18] Lin MY，Jobling TW，Narayan K. Surgical staging of para-aortic LN in patients with locally advanced cervix cancer and no evidence of metastases in preoperative PET/CT imaging [J]. J Gynecol Oncol，2015，26（4）：352.
[19] Li H，Wu X，Cheng X. Advances in diagnosis and treatment of metastatic cervical cancer[J]. J Gynecol Oncol，2016，27（4）：e43.
[20] Rizzo S，Calareso G，Maccagnoni S，et al. Pre-operative MR evaluation of features that indicate the need of adjuvant therapies in early stage cervical cancer patients. A single-centre experience [J]. Eur J Radiol，2014，83（5）：858-864.
[21] Michael TKMD，Antonio Bosch MD. Is staging laparotomy in cervical cancer justifiable?[J]. Int J Radiation Oncol Biol Phys，1977，2（11）：1235-1238.
[22] Osman MA. Defining the role of neoadjuvant chemotherapy followed by surgery in locally advanced cancer cervix：a meta-analysis of phase Ⅲ trials [J]. J Obstetr Gynecol India，2016（5）：352-357.
[23] Bogani G，Ditto A，Martinelli F，et al. Extraperitoneal robotic-assisted para-aortic lymphadenectomy in gynecologic cancer staging：current evidence [J]. J Minimally Invasive Gynecol，2016，23（4）：489.
[24] Walker JL，Morrison A，DiSilvestro P，et al. A phase Ⅰ/Ⅱstudy of extended field radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in patients with cervical carcinoma metastatic to the para-aortic lymph nodes：a Gynecologic Oncology Group study [J]. Gynecol Oncol，2009，112（1）：78-84.
[25] Li S，Li X，Zhang Y，et al. Development and validation of a surgical-pathologic staging and scoring system for cervical cancer [J]. Oncotarget，2016，7（15）：21054-21063. |
|
|
|
